101 related articles for article (PubMed ID: 26447086)
1. Elevation of Serum Acid Sphingomyelinase Activity in Acute Kawasaki Disease.
Konno Y; Takahashi I; Narita A; Takeda O; Koizumi H; Tamura M; Kikuchi W; Komatsu A; Tamura H; Tsuchida S; Noguchi A; Takahashi T
Tohoku J Exp Med; 2015 Oct; 237(2):133-40. PubMed ID: 26447086
[TBL] [Abstract][Full Text] [Related]
2. Elevation of Serum Acid Sphingomyelinase Activity in Children with Acute Respiratory Syncytial Virus Bronchiolitis.
Yoshida S; Noguchi A; Kikuchi W; Fukaya H; Igarashi K; Takahashi T
Tohoku J Exp Med; 2017 Dec; 243(4):275-281. PubMed ID: 29238000
[TBL] [Abstract][Full Text] [Related]
3. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
4. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
7. Marker of T-cell activation is elevated in refractory Kawasaki disease.
Suzuki H; Suenaga T; Takeuchi T; Shibuta S; Yoshikawa N
Pediatr Int; 2010 Oct; 52(5):785-9. PubMed ID: 20487370
[TBL] [Abstract][Full Text] [Related]
8. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[TBL] [Abstract][Full Text] [Related]
10. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease - A Multicenter Retrospective Study.
Okuma Y; Suda K; Nakaoka H; Katsube Y; Mitani Y; Yoshikane Y; Ichida F; Matsushita T; Shichino H; Shiraishi I; Abe J; Hiroe M; Yoshida T; Imanaka-Yoshida K
Circ J; 2016 Oct; 80(11):2376-2381. PubMed ID: 27746411
[TBL] [Abstract][Full Text] [Related]
11. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
Masuzawa Y; Mori M; Hara T; Inaba A; Oba MS; Yokota S
Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.
Huang YH; Kuo HC; Huang FC; Yu HR; Hsieh KS; Yang YL; Sheen JM; Li SC; Kuo HC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187366
[TBL] [Abstract][Full Text] [Related]
13. Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.
Sakurai Y; Takatsuka H; Onaka M; Takada M; Nishino M
Int Arch Allergy Immunol; 2014; 165(2):111-8. PubMed ID: 25401215
[TBL] [Abstract][Full Text] [Related]
14. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
[TBL] [Abstract][Full Text] [Related]
15. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
16. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease.
Lee KY; Han JW; Lee JS; Whang KT
Acta Paediatr; 2002; 91(2):164-7. PubMed ID: 11952003
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
[TBL] [Abstract][Full Text] [Related]
18. [Changes of serum 25-hydroxyvitamin D3 and interleukin-6 after treatment with intravenous immunoglobulins in children with Kawasaki disease].
Chen Y; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1230-2. PubMed ID: 25176105
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-6 in Kawasaki disease.
Kim DS
Yonsei Med J; 1992 Jun; 33(2):183-8. PubMed ID: 1413896
[TBL] [Abstract][Full Text] [Related]
20. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
